| Application no. and date | 22181403.1 (espacenet) (Federated) (European Patent Register), 20150109 | | Patent/reg. no. and date | DK/EP 4176894, 20240228 | | Publication date | 20230510 | | Priority no. and date | US 201461926226 P, 20140110, US 201461988104 P, 20140502 | | EP pub. no. and date |
EP 4176894 20230510 | | Effective date | | | Applicant/owner | Bioverativ Therapeutics Inc., 225 Second Avenue
Waltham MA 02451, US | | Applicant ref. no. | 1702458 | | Inventor | LIU, Tongyao,
Lexington, MA 02421, US,
CHHABRA, Ekta, Seth,
Framingham, MA 01702, US,
PETERS, Robert T.,
Needham, MA 02492, US,
KULMAN, John,
Belmont, MA 02748, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/36 (2006.01) | | Title | KIMÆRE FAKTOR VIII-PROTEINER OG ANVENDELSER DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2024 00049 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
